UNSPSC 51241504: Atropine/prednisolone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP900. This VA Drug Class (OP900) classifies this compound as belonging to the group OPHTHALMICS, OTHER.

UNSPSC 51241504 Atropine/prednisolone is a Commodity-tier code covering pharmaceutical combinations used in ophthalmic and systemic treatments that state and local governments procure for healthcare delivery, emergency response, and institutional medical programs. The code encompasses fixed-dose or concurrent formulations of atropine, a muscarinic antagonist, and prednisolone, a corticosteroid, sourced through medical supply contracts, pharmacy benefit programs, and direct institutional procurement. State and local issuing bodies—including state health departments, county public health agencies, municipal hospitals and clinics, school district health services, and emergency management offices—acquire these medications to support trauma care, allergic reactions, inflammatory eye conditions, and acute medical episodes.

No recent state and local contract opportunities appear in the available records for UNSPSC 51241504. The code shows no identifiable recent RFP, RFQ, IFB, or ITB activity with posted response dates, issuing-body solicitations, or geographic concentration. This silence may reflect that atropine/prednisolone combinations are typically procured through standing pharmacy benefit agreements, cooperative purchasing consortia (such as state pharmaceutical group-purchasing organizations), or routine reorder processes rather than individual competitive solicitations. Business development professionals should monitor state health department procurement portals, school district health service RFQs, and county emergency medical services contracts for opportunities to supply these medications through broader pharmacy or medical-supplies frameworks.